Skip to main content
logo
MEDICOX Co., Ltd. (KOSDAQ:054180)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,295.00
-270.00 (-10.53%)
At close: Jul 2, 2025

MEDICOX Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
27,66928,16130,61126,87520,29617,449
Revenue Growth
-7.66%-8.00%13.90%32.42%16.32%7.78%
Gross Profit
2,0932,1131,9841,853494.97433.65
Operating Income
-4,927-5,917-10,791-12,911-13,873-10,187
Net Income
-10,582-11,895-21,435-34,427-42,619-23,935
Earnings Per Share
-1643.84-2209.34-5587.00-17826.17-30267.49-27125.52
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,1523,4936,02817,68924,76818,742
Total Debt
10,58210,81118,71616,51918,14519,624
Net Cash (Debt)
-7,430-7,318-12,6881,1706,624-881.79
Net Cash Growth
----82.34%--
Net Cash Per Share
-1154.12-1359.11-3307.13605.844704.05-999.35

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1,287-3,432-6,633-8,892-9,156-7,244
Capital Expenditures
-814.31-774.02-366.46-447.75-3,700-1,563
Free Cash Flow
-2,101-4,206-7,000-9,340-12,855-8,807
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.56%7.51%6.48%6.90%2.44%2.48%
Operating Margin
-17.81%-21.01%-35.25%-48.04%-68.35%-58.38%
Pretax Margin
-37.78%-41.78%-70.23%-115.91%-205.97%-137.19%
Profit Margin
-38.25%-42.24%-70.02%-128.10%-209.99%-137.17%
FCF Margin
-7.60%-14.94%-22.87%-34.75%-63.34%-50.47%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.460.450.621.334.135.31